Breaking News Instant updates and real-time market news.

ABT

Abbott

09:17
10/19/16
10/19
09:17
10/19/16
09:17

Abbott sees pediatric nutrition issues in China being near-term in nature

On the company's Q3 earnings call, Abbott Laboratories CEO Miles White attributed the 1% decline in nutrition sales to soft performance in China pediatric nutrition. "As you may recall, I expressed caution on the near-term outlook in China in our last earnings call. Over the last few months, market conditions have remained challenging there, including rapid channel shifts and new safety regulations that are driving an oversupply of product in the market, and aggressive levels of discounting. Although conditions are expected to remain challenging in the near term, the long-term fundamentals of the market remain attractive. We have the right portfolio of products for the various channels, and the best-in-class global supply network. We have also continued to focus on strengthening our competitiveness in order to deliver growth over the long term," White said, adding that the company continues to perform well in Southeast Asia and Latin America and saw above-market growth in U.S. pediatric nutrition.

  • 19

    Oct

  • 21

    Oct

  • 06

    Nov

ABT Abbott

10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.

TODAY'S FREE FLY STORIES

ATVI

Activision Blizzard

$45.08

-0.15 (-0.33%)

10:41
02/24/17
02/24
10:41
02/24/17
10:41
Options
Activision short-term calls active as shares tick higher »

Activision short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

DOC

Physicians Realty Trust

$20.01

0.1 (0.50%)

10:40
02/24/17
02/24
10:40
02/24/17
10:40
Syndicate
Breaking Syndicate news story on Physicians Realty Trust »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

10:39
02/24/17
02/24
10:39
02/24/17
10:39
Conference/Events
CLSA technology/internet analyst holds an analyst/industry conference call »

Technology Analyst James…

RY

Royal Bank of Canada

$74.47

-0.41 (-0.55%)

10:37
02/24/17
02/24
10:37
02/24/17
10:37
Periodicals
RBC places Asia wealth business under review, Reuters reports »

Royal Bank of Canada has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SB

Safe Bulkers

$1.38

0.009 (0.66%)

10:36
02/24/17
02/24
10:36
02/24/17
10:36
Upgrade
Safe Bulkers rating change  »

Safe Bulkers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 22

    Mar

STX

Seagate

$47.39

0.04 (0.08%)

10:36
02/24/17
02/24
10:36
02/24/17
10:36
Options
Seagate put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

10:35
02/24/17
02/24
10:35
02/24/17
10:35
General news
The 3.7% U.S. January new home sales bounce »

The 3.7% U.S. January new…

SQ

Square

$17.23

0.075 (0.44%)

, TEX

Terex

$29.53

-0.38 (-1.27%)

10:31
02/24/17
02/24
10:31
02/24/17
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

SQ

Square

$17.23

0.075 (0.44%)

TEX

Terex

$29.53

-0.38 (-1.27%)

AERI

Aerie Pharmaceuticals

$44.25

-0.2 (-0.45%)

CLSD

Clearside Biomedical

$6.90

-0.29 (-4.03%)

PSTB

Park Sterling Bank

$12.07

-0.03 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 07

    Mar

  • 21

    Mar

  • 21

    Mar

  • 15

    May

HPE

HP Enterprise

$22.46

-2.205 (-8.94%)

, W

Wayfair

$38.32

-0.265 (-0.69%)

10:31
02/24/17
02/24
10:31
02/24/17
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

HPE

HP Enterprise

$22.46

-2.205 (-8.94%)

W

Wayfair

$38.32

-0.265 (-0.69%)

RIG

Transocean

$14.06

-0.25 (-1.75%)

GT

Goodyear Tire

$35.50

-0.45 (-1.25%)

JACK

Jack in the Box

$96.70

-6.9 (-6.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$13.44

-0.25 (-1.83%)

, AMCX

AMC Networks

$59.84

2.34 (4.07%)

10:31
02/24/17
02/24
10:31
02/24/17
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

WEN

Wendy's

$13.44

-0.25 (-1.83%)

AMCX

AMC Networks

$59.84

2.34 (4.07%)

CHK

Chesapeake

$5.81

0.055 (0.96%)

INTU

Intuit

$120.70

1.27 (1.06%)

HP

Helmerich & Payne

$68.53

-0.24 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

MBLY

Mobileye

$46.54

-1.6 (-3.32%)

, NVDA

NVIDIA

$100.49

-10.27 (-9.27%)

10:25
02/24/17
02/24
10:25
02/24/17
10:25
Hot Stocks
Citron closes NVIDIA short, shifts focus to Mobileye »

Andrew Left's Citron…

MBLY

Mobileye

$46.54

-1.6 (-3.32%)

NVDA

NVIDIA

$100.49

-10.27 (-9.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

  • 16

    Mar

  • 20

    Mar

10:25
02/24/17
02/24
10:25
02/24/17
10:25
General news
Michigan sentiment slipped to an upwardly-revised 96.3 »

Michigan sentiment…

ELNK

EarthLink

$5.85

0.04 (0.69%)

, WIN

Windstream

$7.29

0.07 (0.97%)

10:25
02/24/17
02/24
10:25
02/24/17
10:25
Conference/Events
Windstream to host special shareholder meeting »

Virtual Special…

ELNK

EarthLink

$5.85

0.04 (0.69%)

WIN

Windstream

$7.29

0.07 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

10:25
02/24/17
02/24
10:25
02/24/17
10:25
Conference/Events
Wells Fargo housing analyst holds an analyst/industry conference call »

Senior Housing Analyst…

10:25
02/24/17
02/24
10:25
02/24/17
10:25
Conference/Events
UBS pharma and medical devices analysts hold an analyst/industry conference call »

Major & Specialty…

JNJ

Johnson & Johnson

$122.19

1.2901 (1.07%)

10:25
02/24/17
02/24
10:25
02/24/17
10:25
Conference/Events
Johnson & Johnson hs a conference call hosted by JPMorgan »

JPMorgan Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 14

    Mar

  • 27

    Mar

10:25
02/24/17
02/24
10:25
02/24/17
10:25
Conference/Events
CLSA financial tech analyst holds an analyst/industry conference call »

Financial Technology…

CLVS

Clovis

$57.71

-3.48 (-5.69%)

10:22
02/24/17
02/24
10:22
02/24/17
10:22
Hot Stocks
Clovis reports allegations of misconduct, which it calls 'unfounded' »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$5.85

0.095 (1.65%)

10:21
02/24/17
02/24
10:21
02/24/17
10:21
Options
Renewed interest in Chesapeake Apr 7 calls »

Renewed interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

10:20
02/24/17
02/24
10:20
02/24/17
10:20
General news
Treasury Action: yields rebounded slightly »

Treasury Action: yields…

WIN

Windstream

$7.29

0.07 (0.97%)

, ELNK

EarthLink

$5.85

0.04 (0.69%)

10:20
02/24/17
02/24
10:20
02/24/17
10:20
Conference/Events
EarthLink to host special shareholder meeting »

Special Shareholder…

WIN

Windstream

$7.29

0.07 (0.97%)

ELNK

EarthLink

$5.85

0.04 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

MBLY

Mobileye

$46.81

-1.335 (-2.77%)

10:19
02/24/17
02/24
10:19
02/24/17
10:19
Hot Stocks
Breaking Hot Stocks news story on Mobileye »

Citron sees Mobileye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

$NSD

NASDAQ Market Internals

10:17
02/24/17
02/24
10:17
02/24/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$23.48

-0.27 (-1.14%)

10:16
02/24/17
02/24
10:16
02/24/17
10:16
Options
Micron put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 09

    Mar

  • 20

    Mar

  • 23

    Mar

$NYE

NYSE Market Internals

10:16
02/24/17
02/24
10:16
02/24/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.